mRNA cancer immunotherapies
NHS programme to give head and neck cancer patients fast-track access to mRNA vaccine
More than 11,000 people are diagnosed with head and neck cancers every year in England
UK government publishes 10 Year Health Plan for England to ‘reinvent’ NHS
The plan’s three overarching themes are hospital to community, analogue to digital and sickness to prevention
BioNTech expands mRNA capabilities with $1.25bn CureVac acquisition
The deal will support the advancement of BioNTech’s mRNA-based cancer immunotherapies
BMS and BioNTech partner on solid tumour candidate in deal worth over $11bn
BioNTech’s BNT327 is being evaluated in multiple clinical trials, including phase 3 studies in first-line lung cancer
BioNTech announces £1bn UK investment to boost regional R&D presence
The UK government has also agreed to award the company a grant of up to £129m
UK government’s AMR study highlights importance of appropriate antibiotic use
The UKHSA found that some bacteria are already becoming resistant to ceftazidime/avibactam
Prime minister unveils UK government’s plans to abolish NHS England
The move aims to cut waiting times and free up money for front-line services
UK government launches ‘landmark’ AI breast cancer screening trial
Approximately 55,000 cases of the disease are diagnosed every year in the UK
UK study shows RSV vaccine could reduce antibiotic use and antimicrobial resistance
The new analysis found that RSV infections lead to 640,000 antibiotic prescriptions every year
Pfizer/BioNTech’s KP.2-adapted COVID-19 vaccine receives CHMP recommendation
The updated vaccine was shown to generate an improved response against currently circulating variants
UK government launches £400m investment programme to support clinical research
Up to 18 clinical trial hubs will be created to accelerate the development of new drugs
FDA approves updated COVID-19 vaccines to better protect against current variants
Adapted vaccines from Pfizer/BioNTech and Moderna have been authorised for individuals aged six months and older